Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.
about
Oxycodone for neuropathic pain and fibromyalgia in adultsOpioids for neuropathic painOpioids for neuropathic painTramadol for neuropathic painOpioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.Neuropathic pain: a practical guide for the clinicianLong-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain SocietyOxycodone for neuropathic pain in adultsHerpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and TreatmentA comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer painDiabetic neuropathic pain: Physiopathology and treatmentAnimal models of peripheral neuropathiesMolecular mechanisms underlying the enhanced analgesic effect of oxycodone compared to morphine in chemotherapy-induced neuropathic painCarbamazepine potentiates the effectiveness of morphine in a rodent model of neuropathic painContinuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathyGuidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Evidence and consensus recommendations for the pharmacological management of pain in India.Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.Optimizing the use of patient data to improve outcomes for patients: narcotics for chronic noncancer pain.Diabetic neuropathy: mechanisms to managementThe management of diabetic neuropathy in CKD.Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Painful diabetic neuropathy: advantage of novel drugs over old drugs?Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials.Daily average consumption of 2 long-acting opioids: an interrupted time series analysis.Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings.Meta-analysis of dropout rates in randomized controlled clinical trials: opioid analgesia for osteoarthritis pain.Challenges in the development of novel treatment strategies for neuropathic pain.Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.Pharmacologic therapies for complex regional pain syndrome.The long-term safety and efficacy of opioids: a survey of 84 selected patients with intractable chronic noncancer painLong-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain.Combining opioid and adrenergic mechanisms for chronic pain.Treatment of painful diabetic neuropathyEFNS guidelines on pharmacological treatment of neuropathic pain.Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment
P2860
Q24193845-8E5BA580-BE49-4972-9011-BECC7E37CA3BQ24200179-70333F3A-FAFD-4908-85D0-7907228167A7Q24245218-54D7E0A8-808A-4268-A125-69AE70F716EAQ24245564-7125C22E-F1CA-4D7F-B4F9-5CA8D7203248Q24547899-28F18825-BC30-490D-9BCA-5E6C73DA18A2Q24553796-1CF3B1E3-C0AE-41C3-87F2-92E39C2CA3D5Q24598228-4C2DCA88-0B34-4B5D-A214-A906722A2CBEQ24657295-1D7C474A-D40B-4C6B-A78F-EB45D87D1631Q26470985-3AE2C3D7-DB77-475B-9CED-D6D8CC4965EEQ26801569-48AE45EE-1251-47D3-8E99-9BD1455ADD1CQ26991960-FB11E260-8AA5-4F33-9C5F-D8E8583E6A4FQ27004604-195A8812-DE21-4BAB-9336-D063170C8968Q27028046-B2ED9168-7AAB-4465-8C01-6719CF0EE307Q27316467-A0B4AF1D-8472-48B3-BF80-DA29355EFD48Q28542981-89DC8510-60EE-4AF0-9F90-BC3BD4BC6ABEQ28580927-5A7CA308-BFB1-477C-8972-351E93AEED44Q30537158-5DCBF22F-4ECF-43F7-9172-EF6C38531B92Q30844805-B8D1B72A-54D3-4AE1-B63B-1EDD67B1D64BQ33408025-9CA5E862-B66C-4E75-B941-4E0FDF68DBC5Q33436392-5C815F81-82B6-4733-BF4B-E7A678058625Q33554384-52522507-77BD-4793-85DD-AD0C4ACE9617Q33554396-C82A8F7A-EB7B-4D59-B1F3-4A595838683BQ33561260-F387A26D-3DA6-45B2-B192-EA6987F2C6AFQ33583006-C5E83D46-E04D-4D65-B5D1-5F72F834D21AQ33610824-1A7D50CA-647F-4C48-AEDA-B7B9B1A12FA7Q33709851-D0AEA90F-F55A-4697-BBD5-C15CA5BBDDE5Q33714835-295DC612-4917-4676-99E5-38D6762F2E0CQ33793250-18D4746E-ABA9-4A2A-93EF-D3486ABB63DDQ33880187-B300CB09-FB94-49CB-905B-3221244F59D0Q33912585-673FFDF9-8800-476C-9E20-D5465E189834Q33947001-D86A09B7-CFC0-4448-98AB-3C36FE3507B6Q34030400-DF71FBA2-3224-4C79-A9FD-F39CC046ACEFQ34038997-379F8E6D-2D18-406F-8EED-C83A1D117796Q34111647-9D3C81D6-E087-4B49-977E-CC99B1703770Q34167814-333B7CE0-1CA1-4BB8-AEED-AD304EB6B478Q34434307-F4D8C98D-7BDF-4624-8888-D6300A7BEE07Q34456265-9369081A-EB33-42DE-9441-E159A527F55FQ34573607-60FB59E7-50FA-44ED-836F-FC441A1CA3CEQ34595383-5D83B285-F011-48A1-953F-69F5F9482742Q34608990-C2EFBB56-4E7C-4410-80E1-CA92772311F8
P2860
Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Controlled-release oxycodone r ...... n painful diabetic neuropathy.
@en
Controlled-release oxycodone r ...... n painful diabetic neuropathy.
@nl
type
label
Controlled-release oxycodone r ...... n painful diabetic neuropathy.
@en
Controlled-release oxycodone r ...... n painful diabetic neuropathy.
@nl
prefLabel
Controlled-release oxycodone r ...... n painful diabetic neuropathy.
@en
Controlled-release oxycodone r ...... n painful diabetic neuropathy.
@nl
P2093
P1433
P1476
Controlled-release oxycodone r ...... n painful diabetic neuropathy.
@en
P2093
Allan Gordon
C Peter N Watson
Dwight Moulin
John Eisenhoffer
Judith Watt-Watson
P356
10.1016/S0304-3959(03)00160-X
P407
P577
2003-09-01T00:00:00Z